Brighid Morgan is a Program Officer on R4D’s Market Shaping Practice. She focuses on increasing access to maternal, newborn, and child health and nutrition products in low- and middle-income countries, with a particular interest in reducing anemia and micronutrient deficiencies in women of reproductive age.
Ms. Morgan provides technical leadership in market analysis, financing, and policy strategies to improve the availability and affordability of essential health and nutrition commodities. She currently provides technical and programmatic support to the Market Shaping for Multiple Micronutrient Supplements (MMS) for Antenatal Care project to help countries introduce and scale up MMS across antenatal care platforms to improve pregnancy and birth outcomes. She helped develop the MMS Roadmap Costing Tool and trains governments and partner organizations on costing MMS implementation plans. She also played a key role in the 2024 Maternal, Newborn, and Child Health and Nutrition (MNCNH) Market Analysis, offering expertise in methodology development and data analytics, and continues to support projects in the MNCH portfolio.
Ms. Morgan is a Core Member of the Anaemia Action Alliance, a multistakeholder initiative hosted by the World Health Organization, where she collaborates with global partners to drive action on anemia reduction.
Before joining R4D, Ms. Morgan conducted qualitative research in The Gambia on the link between public health nutrition and climate smart agriculture. Prior to graduate school, she worked as a drug discovery researcher at a biotech start-up, where she contributed to projects on novel therapeutics for cancers and autoimmune diseases.
Ms. Morgan holds an MSc in Public Health from the London School of Hygiene and Tropical Medicine and a BS in Neuroscience with a minor in Peace and Justice Studies from Fordham University. She is based in Washington, D.C.
